tadalafil

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Impotence

Conditions

Impotence

Trial Timeline

Jul 1, 2003 → Mar 1, 2004

NCT ID

NCT00547417

About tadalafil

tadalafil is a phase 3 stage product being developed by Eli Lilly for Impotence. The current trial status is completed. This product is registered under clinical trial identifier NCT00547417. Target conditions include Impotence.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (13)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02252367	Approved	Completed	Dec 1, 2015	Jun 1, 2020	Prostatic Hyperplasia
NCT02224846	Approved	Completed	Oct 1, 2014	May 1, 2017	Erectile Dysfunction
NCT01326117	Approved	Withdrawn	Apr 1, 2011	Dec 1, 2013	Gastroparesis
NCT01324999	Phase 2/3	Completed	Mar 1, 2011	Oct 1, 2013	Pulmonary Hypertension
NCT01183650	Phase 1	Completed	Jul 1, 2010	Apr 1, 2011	Benign Prostatic Hyperplasia
NCT01066845	Pre-clinical	Completed	Jan 1, 2010	Aug 1, 2014	Pulmonary Arterial Hypertension
NCT00822354	Pre-clinical	Completed	Sep 1, 2008	Apr 1, 2010	Raynaud
NCT00157326	Phase 2	Completed	Sep 1, 2005	Jun 1, 2006	Hypertension
NCT00333281	Approved	Completed	Jun 1, 2005	Aug 1, 2006	Erectile Dysfunction
NCT00422578	Approved	Completed	Oct 1, 2004	Sep 1, 2005	Impotence
NCT00421083	Phase 3	Completed	Sep 1, 2004	Jun 1, 2005	Erectile Dysfunction
NCT00547417	Phase 3	Completed	Jul 1, 2003	Mar 1, 2004	Impotence
NCT00547599	Approved	Completed	Apr 1, 2003	Jan 1, 2004	Impotence

Competing Products

20 competing products in Impotence

See all competitors

Product	Company	Stage	Hype Score
tadalafil	Eli Lilly	Approved	85
tadalafil + sildenafil	Eli Lilly	Approved	85
tadalafil + placebo + tadalafil + tadalafil + tadalafil + placebo	Eli Lilly	Phase 3	77
GPI 1485	Eisai	Phase 2	52
tadalafil + sildenafil	Eli Lilly	Approved	85
tadalafil	Eli Lilly	Approved	85
tadalafil + sildenafil	Eli Lilly	Phase 3	77
tadalafil + placebo + tadalafil + tadalafil	Eli Lilly	Phase 3	77
tadalafil + Placebo	Eli Lilly	Phase 3	77
tadalafil + tadalafil + placebo	Eli Lilly	Phase 3	77
tadalafil + tadalafil + placebo	Eli Lilly	Phase 3	77
Fluvastatin-sodium	Novartis	Phase 3	77
Sildenafil Citrate	Pfizer	Approved	84
UK0369,003 + Cialis (Tadalafil)	Pfizer	Phase 2	51
Viagra (Sildenafil citrate)	Pfizer	Approved	84
sildenafil citrate	Pfizer	Approved	84
Placebo + Viagra (sildenafil citrate)	Pfizer	Approved	84
UK-369,003	Pfizer	Phase 2	51
Viagra (Sildenafil Citrate) 100 mg	Pfizer	Approved	84
Viagra (Sildenafil citrate)	Pfizer	Approved	84

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved

Olanzapine + PlaceboApproved

exenatide and sitagliptin + exenatide and placeboApproved

Tirzepatide + PlaceboApproved

tadalafilApproved